Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 107

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 107
---
 for those meetings;
(ii) at those meetings there are full discussions of, and decisions are made regarding, the key strategic issues affecting us and our
subsidiaries; (iii) those meetings are properly minuted; (iv) at least some of our directors, together with supporting staff, are based
in the United Kingdom; and (v) we have permanent staffed office premises in the United Kingdom sufficient to discharge our functions.

Even if we are considered
by His Majesty’s Revenue and Customs as resident in the United Kingdom for United Kingdom tax purposes, as expected, we would nevertheless
not be treated as resident in the United Kingdom if (a) we were concurrently resident in another jurisdiction (applying the tax residence
rules of that jurisdiction) that has a double tax treaty with the United Kingdom and (b) there is a tiebreaker provision in that tax treaty
which allocates exclusive residence to that other jurisdiction. Because this analysis is highly factual and may depend on future changes
in our management and organizational structure, there can be no assurance regarding the final determination of our tax residence. Should
we be treated as resident for tax purposes in another jurisdiction other than the United Kingdom, we would be subject to taxation in such
jurisdiction in accordance with such jurisdiction’s laws, which could result in additional costs and expenses.

The rights of our shareholders may differ from the rights typically offered to shareholders of a U.S. corporation.

We are incorporated under
English law. The rights of holders of Ordinary Shares and, therefore, certain of the rights of holders of our Depositary Shares, are governed
by English law, including the provisions of the United Kingdom Companies Act 2006, or the Companies Act, and by our Articles of Association.
These rights differ in certain respects from the rights of shareholders in typical U.S. corporations. See “Description of Share Capital—Differences in Corporate Law” for a description of the principal differences between the provisions of the Companies
Act applicable to us and, for example, the Delaware General Corporation Law relating to shareholders’ rights and protections.

| 52 |

Protections found in provisions under the United Kingdom City Code on Takeovers and Mergers may delay or discourage a takeover attempt, including attempts that may be beneficial to holders of our Ordinary Shares and Depositary Shares.

The United Kingdom City Code
on Takeovers and Mergers, or the City Code, applies, among other things, to an offer for a public limited company whose registered office
is in the United Kingdom and has its